Prevalence and Risk Factors of Chronic Kidney Disease in Hypertensive Patients attended at Victoria Chitepo Provincial Hospital Mutare Zimbabwe, 2022

M.T. Mahamane Salissou¹ , T. Shumba² , A.R. Mahaman Yacoubou³ , S. Makengo Olivier⁴

Section:Research Paper, Product Type: Journal-Paper
Vol.10 , Issue.3 , pp.21-28, Jun-2023

Online published on Jun 30, 2023

Copyright © M.T. Mahamane Salissou, T. Shumba, A.R. Mahaman Yacoubou, S. Makengo Olivier . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
Hypertension and chronic kidney disorders (CKD) are key public health burdens in Zimbabwe .In this study we evaluate the prevalence and risk factors of CKD in hypertensive patients attended at Victoria Chitepo Provincial Hospital in Mutare from July to October 2022.This was an analytical cross sectional study which investigated in a retrospective manner the medical records of patients with hypertension to determine those who developed CKD. The clinical characteristics and GFR were used to determine the stage of CKD. Random sampling method was used to choose 220 participants from the biochemistry results book to get Urea and electrolytes test results, age, race, gender, location of residence, whether patient had diabetes mellitus and on any antihypertensive medication .Out of 220 cases 71 (32.3%) had developed CKD at different stages as follow : 16.9% in stage 1, 22.5% in stage 2, 49.3% in stage 3, 7.1% in stage 4 and 4.2% were in stage 5. Furthermore 39 (55%) were female and 32 (45%) male. 11(15.5%) participants were below 30 years old, 23 (32.4%) were between the ages of 30 and 50 and 37 (52.1%) participants were over 50 years old. Of the 71 participants, 100% were all black. About 28 cases (39.4%) of the participants also had Diabetes Mellitus. 23 (32.4%) participants were not on any antihypertensive drugs. 22.5% were from the rural areas, 32.4% were from semi-urban areas and 45.1% were from urban areas. Risk factors analysis indicated statistical significance between Hypertension induced CKD with regards to gender OR 1.96 CI (1.09- 3.51), P=0.023, History of diabetes mellitus OR 2.58 CI (1.38-4.81), P= 0.0024, History of antihypertensive medication OR 0.46, CI (0.24-0.88), P= 0.018.There is high burden of CKD among patients with hypertension in this study. Gender, Increasing age, Race, diabetes mellitus and use of antihypertensive drugs and location of residence are significantly associated with CKD in hypertensive patients.

Key-Words / Index Term :
Hypertension, Prevalence, chronic, kidney disease, risk factors, Hospital.

References :
[1] B. Xue and A. K. Johnson, "Sensitization of Hypertension: The Impact of Earlier Life Challenges: Excellence Award for Hypertension Research 2021," Hypertension, vol. 80, no. 1, pp. 1-12, 2023.
[2] K. Mills, A. Stefanescu, and J. He, "The global epidemiology of hypertension. Nature reviews. Nephrology, 16(4), 223–237,2020.
[3] K. T. Mills et al., "Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation.," 2016.
[4] S. O. Ajayi et al., ". Prevalence of Chronic Kidney Disease as a Marker of Hypertension Target Organ Damage in Africa," 2021.
[5] J. Mufunda et al., "Correlates of blood pressure in an urban Zimbabwean population and comparison to other populations of African origin," Journal of Human Hypertension, vol. 14, no. 1, pp. 65-73, 2000.
[6] S. R. Vaidya and N. R. Aeddula, "Chronic Renal Failure. Treasure Island (FL): StatPearls Publishing ,2022.
[7] "How blood pressure can lead to kidney damage or failure," 2022.
[8] S. Oza et al., "Hypertension management in MSF programmes in Jordan and Zimbabwe: oppotunities for simplification and use of fixed-dose combination medications," 2020.
[9] M. P. Mutowo, J. C. Mangwiro, P. K. Lorgelly, A. J. Owen, and A. Renzaho, "Hypertension in Zimbabwe: a meta-analysis to quantify its burden and policy implications," World Journal of Meta-Analysis, pp. 54-60, 2015.
[10] R. Agarwal et al., "A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease," Clinical kidney journal, vol. 16, no. 2, pp. 293-302, 2023.
[11] O. J. Oluwademilade, G. O. Ajani, F. T. Kolawole, O. O. Obajolowo, and E. O. Olabinri, "Burden of chronic kidney disease in hypertensive patients in medical outpatient clinic of a Rural Tertiary Hospital," J Hypertens Manag, vol. 6, p. 049, 2020.
[12] S.-Z. Jiang, W. Lu, X.-F. Zong, H.-Y. Ruan, and Y. Liu, "Obesity and hypertension. Experimental and therapeutic medicine, 12(4), 2395–2399, 2016.
[13] K. Kumela Goro et al., "Patient Awareness, Prevalence, and Risk Factors of Chronic Kidney Disease among Diabetes Mellitus and Hypertensive Patients at Jimma University Medical Center, Ethiopia," (in eng), Biomed Res Int, vol. 2019, p. 2383508, 2019.
[14] E. K. Tannor, F. S. Sarfo, L. M. Mobula, O. Sarfo-Kantanka, R. Adu-Gyamfi, and J. Plange-Rhule, "Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: A multicenter cross-sectional study," (in eng), J Clin Hypertens (Greenwich), vol. 21, no. 10, pp. 1542-1550, Oct 2019.
[15] F. F. Kaze, A. P. Kengne, C. T. Magatsing, M. P. Halle, E. Yiagnigni, and K. B. Ngu, "Prevalence and determinants of chronic kidney disease among hypertensive Cameroonians according to three common estimators of the glomerular filtration rate," The Journal of Clinical Hypertension, vol. 18, no. 5, pp. 408-414, 2016.
[16] Y.-P. Zhang et al., "The impact of blood pressure on kidney function in the elderly: a cross-sectional study," Kidney and Blood Pressure Research, vol. 38, no. 2-3, pp. 205-216, 2014.
[17] J. Beckerman "High Blood Pressure and Hypertensive Heart Disease," 2021.
[18] T. Liyanage et al., "Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet (London, England), 385(9981), 1975–1982, 2015.
[19] H. S. M. Anteneh Hunegnaw, Masresha Asmare Techane and Chilot Desta Agegnehu, "Prevalence and Associated Factors of Chronic Kidney Disease among Adult Hypertensive Patients at Northwest Amhara Referral Hospitals, Northwest Ethiopia, 2020," ed, 2021.
[20] A. Hunegnaw, H. S. Mekonnen, M. A. Techane, and C. D. Agegnehu, "Prevalence and Associated Factors of Chronic Kidney Disease among Adult Hypertensive Patients at Northwest Amhara Referral Hospitals, Northwest Ethiopia, 2020," (in eng), Int J Hypertens, vol. 2021, p. 5515832, 2021.
[21] L. C. Zulu, E. Kalipeni, and E. Johannes, "Analyzing spatial clustering and the spatiotemporal nature and trends of HIV/AIDS prevalence using GIS: the case of Malawi, 1994-2010," BMC infectious diseases, vol. 14, no. 1, pp. 1-21, 2014.
[22] J. Coresh, "Update on the burden of CKD," Journal of the American Society of Nephrology, vol. 28, no. 4, pp. 1020-1022, 2017.
[23] D. M. Kemigisa, "Lifestyle and Health: Understanding the prevalence of hypertension among the elderly persons in Kiruddu Referral Hospital, Kampala District," 2021.
[24] L. S. Da Silva et al., "Hidden prevalence of chronic kidney disease in hypertensive patients: the strategic role of primary health care," Public health, vol. 140, pp. 250-257, 2016.
[25] A. C. Webster, E. V. Nagler, R. L. Morton, and P. Masson, "Chronic kidney disease," The lancet, vol. 389, no. 10075, pp. 1238-1252, 2017.
[26] C. Osafo , M. Mate-Kole, K. Affram, and D. Adu, "Prevalence of Chronic Kidney Disease in Hypertensive Patients in Ghana," 2011.
[27] O. A. Akpor, A. O. Adeoye, F. A. Ibitoba, and O. B. Akpor, "Prevalence of Chronic Kidney Disease Among Diabetes and Hypertensive in a Teaching Hospital in Ekiti State, Southwest Nigeria," 2022.
[28] L. Anselin, S. Sridharan, and S. Gholston, "Using exploratory spatial data analysis to leverage social indicator databases: the discovery of interesting patterns," Social Indicators Research, pp. 287-309, 2007.
[29] W. Chen et al., "Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China," Nephrology Dialysis Transplantation, vol. 24, no. 4, pp. 1205-1212, 2009.
[30] H. A. Mohammed and A. M. Taha, "Histopathological Effects of Cadmium Chloride on the Kidney in Japanese Quail," Int. J. Sci. Res. in Biological Sciences Vol, vol. 8, no. 4, 2021.